SHSE:688506 (China)
Â
Class A
Â¥
238.62
-7.02 (-2.86%)
Sep 11
Business Description
Sichuan Biokin Pharmaceutical Co Ltd
ISIN : CNE100006FN4
Share Class Description:
SHSE:688506: Class ATotal Employee Number:
3,198Compare
Compare
Traded in other countries / regions
688506.China Index Membership
SSE Composite IndexCSI 300 Index IPO Date
2023-01-06Description
Sichuan Biokin Pharmaceutical Co Ltd is a chemical drug and biological drug-based company that integrates drug research and development, production and marketing.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.96 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 1.14 | |||||
Debt-to-EBITDA | -4.5 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 10.73 | |||||
Beneish M-Score | 0.57 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 47.6 | |||||
3-Year EBITDA Growth Rate | -32.8 | |||||
3-Year EPS without NRI Growth Rate | -45.9 | |||||
3-Year FCF Growth Rate | -48.1 | |||||
3-Year Book Growth Rate | 90.3 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 25.86 | |||||
9-Day RSI | 28.48 | |||||
14-Day RSI | 32.62 | |||||
3-1 Month Momentum % | 42.83 | |||||
6-1 Month Momentum % | 15.6 | |||||
12-1 Month Momentum % | -10.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.23 | |||||
Quick Ratio | 4.16 | |||||
Cash Ratio | 2.16 | |||||
Days Inventory | 241.95 | |||||
Days Sales Outstanding | 61.04 | |||||
Days Payable | 875.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1 | |||||
Shareholder Yield % | -1.73 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 90.35 | |||||
Operating Margin % | -46.64 | |||||
Net Margin % | -62.02 | |||||
EBITDA Margin % | -45.93 | |||||
FCF Margin % | -62.62 | |||||
OCF Margin % | -47.34 | |||||
ROE % | -29.29 | |||||
ROA % | -14.82 | |||||
ROIC % | -27.31 | |||||
3-Year ROIIC % | -21.57 | |||||
ROC (Joel Greenblatt) % | -29.65 | |||||
ROCE % | -13.56 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 1610.72 | |||||
Shiller PE Ratio | 530.27 | |||||
PS Ratio | 38.22 | |||||
PB Ratio | 21.36 | |||||
Price-to-Tangible-Book | 21.5 | |||||
EV-to-EBIT | -82.89 | |||||
EV-to-EBITDA | -82.89 | |||||
EV-to-Revenue | 38.07 | |||||
EV-to-FCF | -60.79 | |||||
Price-to-GF-Value | 0.83 | |||||
Price-to-Projected-FCF | 25.09 | |||||
| Price-to-Net-Current-Asset-Value | 29.17 | |||||
Earnings Yield (Greenblatt) % | -1.21 | |||||
FCF Yield % | -1.61 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sichuan Biokin Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,536.251 | ||
| EPS (TTM) (Â¥) | -3.79 | ||
| Beta | 0.6384 | ||
| 3-Year Sharpe Ratio | 0.92 | ||
| 3-Year Sortino Ratio | 1.76 | ||
| Volatility % | 39.22 | ||
| 14-Day RSI | 32.62 | ||
| 14-Day ATR (Â¥) | 13.341373 | ||
| 20-Day SMA (Â¥) | 266.9675 | ||
| 12-1 Month Momentum % | -10.37 | ||
| 52-Week Range (Â¥) | 200.1 - 404 | ||
| Shares Outstanding (Mil) | 412.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sichuan Biokin Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sichuan Biokin Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sichuan Biokin Pharmaceutical Co Ltd Frequently Asked Questions
What is Sichuan Biokin Pharmaceutical Co Ltd(SHSE:688506)'s stock price today?
The current price of SHSE:688506 is ¥238.62. The 52 week high of SHSE:688506 is ¥404.00 and 52 week low is ¥200.10.
When is next earnings date of Sichuan Biokin Pharmaceutical Co Ltd(SHSE:688506)?
The next earnings date of Sichuan Biokin Pharmaceutical Co Ltd(SHSE:688506) is .
Does Sichuan Biokin Pharmaceutical Co Ltd(SHSE:688506) pay dividends? If so, how much?
Sichuan Biokin Pharmaceutical Co Ltd(SHSE:688506) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers